Investigation of tissue inhibitor of metalloproteinases 1 in plasma from colorectal cancer patients and blood donors by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry

被引:0
作者
Caspersen, M. B.
Sorensen, N. M.
Schrohl, A. S.
Iversen, P.
Nielsen, H. J.
Brunner, N.
机构
[1] Univ Copenhagen, Dept Vet Pathobiol, Fac Life Sci, DK-1870 Frederiksberg C, Denmark
[2] Ciphergen Biosyst, Copenhagen, Denmark
[3] Hvidovre Univ Hosp, Dept Surg Gastroenterol, DK-2650 Hvidovre, Denmark
关键词
colorectal cancer; TIMP-1; SELDI TOF MS; ELISA; protein isoforms;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Early detection of colorectal cancer (CRC) improves patient survival. Plasma tissue inhibitor of metalloproteinases 1 (TIMP-1) measurements by enzyme-linked immunosorbent assay (ELISA) have been suggested as a new method for the early detection of CRC. To further investigate the nature of TIMP-1 in plasma, surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI TOF MS) was used. TIMP-1 measurements of plasma from 16 healthy donors and 14 CRC patients were performed using TIMP-1 monoclonal antibody in SELDI TOF MS and ELISA. SELDI TOF MS applying an antibody to TIMP-1 revealed that human plasma TIMP-1 has a mass of 25.1 kDa and exhibits several isoforms. Both methods showed increased plasma TIMP-1 values for cancer patients as compared to healthy individuals. The p values for the separation of the groups were 0.0019 for ELISA and < 0.0001 for SELDI TOF MS. CRC did not fundamentally affect the appearance of TIMP-1 as evaluated by SELDI TOF MS.
引用
收藏
页码:89 / 94
页数:6
相关论文
共 20 条
[1]   Expression of tissue inhibitor of metalloproteinase-1 protein and messenger ribonucleic acid by the oviduct of cyclic, early-pregnant, and ovariectomized steroid-treated gilts [J].
Buhi, WC ;
Alvarez, IM ;
Pickard, AR ;
McIntush, EW ;
Kouba, AJ ;
Ashworth, CJ ;
Smith, MF .
BIOLOGY OF REPRODUCTION, 1997, 57 (01) :7-15
[2]   SEQUENCE OF HUMAN-TISSUE INHIBITOR OF METALLOPROTEINASES AND ITS IDENTITY TO ERYTHROID-POTENTIATING ACTIVITY [J].
DOCHERTY, AJP ;
LYONS, A ;
SMITH, BJ ;
WRIGHT, EM ;
STEPHENS, PE ;
HARRIS, TJR ;
MURPHY, G ;
REYNOLDS, JJ .
NATURE, 1985, 318 (6041) :66-69
[3]  
FUNG ET, 2004, PRECLINICA, V2, P253
[4]   Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1 [J].
GomisRuth, FX ;
Maskos, K ;
Betz, M ;
Bergner, A ;
Huber, R ;
Suzuki, K ;
Yoshida, N ;
Nagase, H ;
Brew, K ;
Bourenkov, GP ;
Bartunik, H ;
Bode, W .
NATURE, 1997, 389 (6646) :77-81
[5]   Randomised controlled trial of faecal-occult-blood screening for colorectal cancer [J].
Hardcastle, JD ;
Chamberlain, JO ;
Robinson, MHE ;
Moss, SM ;
Amar, SS ;
Balfour, TW ;
James, PD ;
Mangham, CM .
LANCET, 1996, 348 (9040) :1472-1477
[6]   Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer [J].
Holten-Andersen, MN ;
Murphy, G ;
Nielsen, HJ ;
Pedersen, AN ;
Christensen, IJ ;
Hoyer-Hansen, G ;
Brünner, N ;
Stephens, RW .
BRITISH JOURNAL OF CANCER, 1999, 80 (3-4) :495-503
[7]  
Holten-Andersen MN, 2000, CLIN CANCER RES, V6, P4292
[8]  
Holten-Andersen MN, 2002, CLIN CANCER RES, V8, P156
[9]  
Holten-Andersen MN, 2002, CLIN CHEM, V48, P1305
[10]   Randomised study of screening for colorectal cancer with faecal-occult-blood test [J].
Kronborg, O ;
Fenger, C ;
Olsen, J ;
Jorgensen, OD ;
Sondergaard, O .
LANCET, 1996, 348 (9040) :1467-1471